Therefore, if SDH genetic testing of an SDHB-immunonegative tumor does not show a mutation, SDHC promoter methylation, VHL, and/orNF1 molecular testing is recommendable (Oudijk et al., 2019; Papathomas et al., 2015). This evidence concerns the gene VHL and neoplasm.